CureMeAbroad, a global medical tourism discovery and concierge platform, has announced that it has surpassed $5 million in Annual Run Rate (ARR) within its first year of operations, reflecting rising international demand for affordable, high-quality healthcare overseas.

The platform connects patients from the United States, United Kingdom, Germany, Australia and GCC countrieswith a network of more than 370 accredited hospital partners across India, Thailand, Turkey, Mexico, South Korea and Georgia.

Since its launch, CureMeAbroad has evolved from a treatment discovery marketplace into a full-service patient journey platform, offering support across treatment research, teleconsultations, hospital coordination, travel arrangements and post-treatment follow-up.

Commenting on the milestone, Aditya Oza, CEO and Co-Founder of CureMeAbroad, said, "The $5 million Annual Run Rate is a strong validation for our product-market fit. Patients across five major source markets are increasingly choosing a structured platform for one of the most important decisions of their lives.”

“The traditional model of medical travel through referral networks and opaque agents is giving way to a transparent, accredited and technology-enabled ecosystem, and we are building the infrastructure for that shift,” Oza added.

According to CureMeAbroad, Turkey and Thailand currently attract the highest inbound patient volumes from Western countries, while India and Mexico are witnessing increasing demand for treatments in oncology, orthopaedics and reproductive health. 

Mikhail Bohra, Co-Founder and Chief Marketing Officer of CureMeAbroad, said, "We built CureMeAbroad as a volume-plus-value play from day one. The discovery marketplace brings in patients at scale, while the concierge arm serves those seeking end-to-end guidance. That combination has enabled us to grow without relying heavily on paid customer acquisition.”

The announcement comes as the global medical tourism industry continues to expand. According to Grand View Research, the market is projected to reach $126.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 14.1%.